Back to MORGAN STANLEY MORGAN STANLEY

MRNSMRNS
4 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in MARINUS PHARMACEUTICALS INC

As of its Q4 2024 13F, Morgan Stanley held 3,299,229 shares of MRNS (Marinus Pharmaceuticals), worth $1.8M. Morgan Stanley's 13F filings listed MRNS from Q2 2024 to Q4 2024, 3 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$210,381

Total Shares Change

-179,812

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Increased
3.3M
+1898.7%
$1.8M0.0%—
42
2024-Q3
Decreased
165,068
-8.2%
$290,5200.0%—
0
2024-Q2
First report
179,812
-
$210,3810.0%—
0

Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used